Funding for this research was provided by:
Queen’s University Department of Medicine Innovation Fund
Received: 24 June 2020
Accepted: 11 November 2020
First Online: 5 January 2021
Compliance with ethical standards
: Stephen Scott is the co-founder and CSO of Kinarm that commercializes the robotic technology used in the present study. Jessica Vanderlinden, J. Gordon Boyd and Rachel Holden have no conflicts of interest to report.
: The study was approved by Queen’s University and Affiliated Hospitals Health Sciences Research Ethics Board.
: Each patient gave informed consent prior to any assessment or data collection.